help button home button Am J Pathol Epitomics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scarpino, S.
Right arrow Articles by Ruco, L. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scarpino, S.
Right arrow Articles by Ruco, L. P.
(American Journal of Pathology. 2000;156:831-837.)
© 2000 American Society for Investigative Pathology

Regular Articles

Papillary Carcinoma of the Thyroid

Hepatocyte Growth Factor (HGF) Stimulates Tumor Cells to Release Chemokines Active in Recruiting Dendritic Cells

Stefania Scarpino*, Antonella Stoppacciaro*, Francesca Ballerini*, Maurizio Marchesi{dagger}, Maria Prat{ddagger}, M. Cristina Stella§, Silvano Sozzani, Paola Allavena, Alberto Mantovani and Luigi P. Ruco*

From the Dipartimento di Medicina Sperimentale e Patologia,*
and Istituto di III Clinica Chirurgica,{dagger}
Cattedra di Chirurgia Generale (Prof. Francesco P. Campana), Università "La Sapienza", Roma; the Dipartimento di Scienze Mediche,{ddagger}
Università del Piemonte Orientale "A. Avogadro", Novara; the Istituto per la Ricerca sul Cancro (IRCC),§
Università di Torino, Torino; and the Istituto di Ricerche Farmacologiche Mario Negri,
Milano, Italy

Tissue distribution of dendritic cells was investigated in eight cases of papillary carcinoma of the thyroid using immunohistochemistry. Most dendritic cells had an immature phenotype (CD1a++, CD11c+, CD40+, CD86-, HLA-DR-) and were located at the invasion edge of the tumor. This pattern of distribution was profoundly different from that of CD68+ macrophages, which were evenly distributed throughout the tumor. The ability of tumor cells to release chemotactic factors active on dendritic cells was investigated in primary cultures of the same cases of papillary carcinoma, and was compared to that of the corresponding normal thyroid cells obtained from the tumor-free contralateral lobe. Chemotactic activity of culture supernatants was tested against dendritic cells in a chemotaxis chamber. It was found that papillary carcinoma cells were active in releasing chemotactic activity, that hepatocyte growth factor (HGF; 100 ng/ml) or interleukin (IL)-1ß (103 U/ml) induced a fourfold increase in the amount of chemotactic activity released, and that normal thyroid cells obtained from the same patients were as effective as tumor cells. Characterization of chemokines at RNA level revealed that unstimulated cells contain large amounts of IL-8 and monocyte chemotactic protein (MCP)-1 RNAs, and that stimulation with HGF or IL-1ß induced RNAs for regulated upon activation normal T expressed and secreted (RANTES), macrophage inflammatory protein (MIP)-3{alpha}, interferon-{gamma}-inducible protein 10 (IP-10), and, to a lesser extent, MIP-1{alpha} and MIP-1ß. The possibility that HGF/Met interaction has a biological role in vivo was investigated in serial sections of six tumors immunostained for CD1a+, Met protein, and HGF. It was found that all six tumors were intensely and diffusely positive for Met protein, that HGF staining was present in tumor cells of the advancing edge, and that HGF+/Met+ tumor cell nests were infiltrated by CD1a+ dendritic cells. The foregoing observations are consistent with the possibility that HGF stimulation of Met+ tumor cells is one of the molecular mechanisms involved in the recruitment of dendritic cells.




This article has been cited by other articles:


Home page
 J. Immunol.Home page
K. Okunishi, M. Dohi, K. Fujio, K. Nakagome, Y. Tabata, T. Okasora, M. Seki, M. Shibuya, M. Imamura, H. Harada, et al.
Hepatocyte Growth Factor Significantly Suppresses Collagen-Induced Arthritis in Mice
J. Immunol., October 15, 2007; 179(8): 5504 - 5513.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. G. Borrello, L. Alberti, A. Fischer, D. Degl'Innocenti, C. Ferrario, M. Gariboldi, F. Marchesi, P. Allavena, A. Greco, P. Collini, et al.
Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene
PNAS, October 11, 2005; 102(41): 14825 - 14830.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Okunishi, M. Dohi, K. Nakagome, R. Tanaka, S. Mizuno, K. Matsumoto, J.-i. Miyazaki, T. Nakamura, and K. Yamamoto
A Novel Role of Hepatocyte Growth Factor as an Immune Regulator through Suppressing Dendritic Cell Function
J. Immunol., October 1, 2005; 175(7): 4745 - 4753.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
M. Cremel, W. Berlier, H. Hamzeh, F. Cognasse, P. Lawrence, C. Genin, J.-C. Bernengo, C. Lambert, M.-C. Dieu-Nosjean, and O. Delezay
Characterization of CCL20 secretion by human epithelial vaginal cells: involvement in Langerhans cell precursor attraction
J. Leukoc. Biol., July 1, 2005; 78(1): 158 - 166.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. Mineo, A. Costantino, F. Frasca, L. Sciacca, S. Russo, R. Vigneri, and A. Belfiore
Activation of the Hepatocyte Growth Factor (HGF)-Met System in Papillary Thyroid Cancer: Biological Effects of HGF in Thyroid Cancer Cells Depend on Met Expression Levels
Endocrinology, September 1, 2004; 145(9): 4355 - 4365.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. P. Russell, J. B. Engiles, and J. L. Rothstein
Proinflammatory Mediators and Genetic Background in Oncogene Mediated Tumor Progression
J. Immunol., April 1, 2004; 172(7): 4059 - 4067.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. Imaizumi, H. Murota, S. Kanda, Y. Hishikawa, T. Koji, T. Taguchi, Y. Tanaka, Y. Yamada, S. Ikeda, T. Kohno, et al.
Expression of the c-Met Proto-Oncogene and Its Possible Involvement in Liver Invasion in Adult T-cell Leukemia
Clin. Cancer Res., January 1, 2003; 9(1): 181 - 187.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
A. P. Vicari, C. Chiodoni, C. Vaure, S. Ait-Yahia, C. Dercamp, F. Matsos, O. Reynard, C. Taverne, P. Merle, M. P. Colombo, et al.
Reversal of Tumor-induced Dendritic Cell Paralysis by CpG Immunostimulatory Oligonucleotide and Anti-Interleukin 10 Receptor Antibody
J. Exp. Med., August 19, 2002; 196(4): 541 - 549.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
P. Romagnani, M. Rotondi, E. Lazzeri, L. Lasagni, M. Francalanci, A. Buonamano, S. Milani, P. Vitti, L. Chiovato, M. Tonacchera, et al.
Expression of IP-10/CXCL10 and MIG/CXCL9 in the Thyroid and Increased Levels of IP-10/CXCL10 in the Serum of Patients with Recent-Onset Graves' Disease
Am. J. Pathol., July 1, 2002; 161(1): 195 - 206.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M.-C. Dieu-Nosjean, C. Massacrier, B. Vanbervliet, W.-H. Fridman, and C. Caux
IL-10 Induces CCR6 Expression During Langerhans Cell Development While IL-4 and IFN-{gamma} Suppress It
J. Immunol., November 15, 2001; 167(10): 5594 - 5602.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. P. Vicari, S. Ait-Yahia, K. Chemin, A. Mueller, A. Zlotnik, and C. Caux
Antitumor Effects of the Mouse Chemokine 6Ckine/SLC Through Angiostatic and Immunological Mechanisms
J. Immunol., August 15, 2000; 165(4): 1992 - 2000.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Society for Investigative Pathology.